Massive Bio Press Releases - EIN Presswire - Press Release Distribution Service

Published on May 31, 2026 - 11:04 GMT

Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026

Reticulum Nexus™ brings together six specialized AI agents in a real-time orchestration layer built for precision oncology access. CHICAGO, IL, UNITED STATES, May 30, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio today announced the next-generation product …

Distribution channels: Chemical Industry, Companies ...

Published on May 29, 2026 - 14:14 GMT

Massive Bio Partners with TOUCH BBCA and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials

AI-powered trial matching now available through two trusted cancer advocacy and navigation platforms BOCA RATON, FL, UNITED STATES, May 29, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio, a global precision oncology company, today announced a new partnership …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on May 28, 2026 - 14:00 GMT

Massive Bio to Unveil Reticulum Nexus™ as the AI Operating System for Oncology Access at ASCO 2026

Bridging cancer innovation and patient access through a trusted multi-agent platform. BOCA RATON, FL, UNITED STATES, May 28, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio, a global leader in AI-enabled oncology trial access and precision oncology navigation, …

Distribution channels: Business & Economy, Companies ...

Published on May 21, 2026 - 14:00 GMT

Massive Bio & BeeKeeperAI Use Federated Confidential Computing to Expand Oncology Access in Atlanta's Underserved Areas

AI-powered pre-screening infrastructure enables scalable, privacy-preserving clinical trial matching across underserved patient populations in Atlanta. BOCA RATON, FL, UNITED STATES, May 21, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio, a leader in AI-enabled …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2026 - 14:00 GMT

Massive Bio and Just Worldwide Announce Strategic Partnership to Connect More Cancer Patients to Clinical Trials

Leading global patient engagement specialist joins forces with AI oncology platform to raise awareness, onboard patients, and expand access to clinical research BOCA RATON, FL, UNITED STATES, May 14, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio, the global …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 28, 2026 - 14:00 GMT

Massive Bio Expands Global Access to Clinical Trials Through AI-Powered Parameterization and Pre-Screening with OpenAI

Through OpenAI's Impact Hours program, Massive Bio is enabling real-time trial parameterization and free pre-screening services in high-population regions. SAN FRANCISCO, CA, UNITED STATES, April 28, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio, a leader …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...

Published on April 9, 2026 - 14:00 GMT

Massive Bio Publishes Prospective Study on AI-Driven Clinical Trial Matching in 3,804 Cancer Patients

Neuro-symbolic AI achieves 4x faster trial matching with 17,000+ oncologist-confirmed matches, published in ESMO Real World Data and Digital Oncology. BOCA RATON, FL, UNITED STATES, April 9, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio Publishes Peer-Reviewed …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on March 19, 2026 - 14:00 GMT

Massive Bio Launches NexusPulse™, the Real-Time AI Signal Engine for Oncology Markets

Turning real-world clinical and biomarker data into always-on analytics and actionable signals for oncology teams. DALLAS, TX, UNITED STATES, March 19, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio today announced the launch of NexusPulse™, a real-time AI …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 2, 2026 - 14:00 GMT

Massive Bio Launches TrialRelay™ at SCOPE 2026: An Operating System to End 'Referral Black Holes' in Oncology

TrialRelay™, powered by the TrialRouter™ AI agent, replaces passive networks with active orchestration for physician-to-physician handoffs. ORLANDO, FL, UNITED STATES, February 2, 2026 /⁨EINPresswire.com⁩/ -- Massive Bio today announced the launch of …

Distribution channels: Business & Economy, Companies ...

Published on November 18, 2025 - 18:23 GMT

Massive Bio Collaborates with the American Cancer Society to Accelerate Equitable Access to Cancer Clinical Trials

AI-driven trial matching and patient-centric support strengthen the American Cancer Society’s effort to reduce barriers and broaden participation nationwide. BOCA RATON, FL, UNITED STATES, November 18, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio today …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 14, 2025 - 07:21 GMT

Massive Bio Announces Reticulum Nexus - an AI-Driven Multi Agent Platform orchestrating the end-to-end patient journey

BERLIN, GERMANY, November 14, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio today introduced Reticulum Nexus, the company’s most significant technological leap to date: a patient-centric, multi-agent platform engineered to coordinate the full oncology journey, …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on October 17, 2025 - 16:45 GMT

Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown

Massive Bio urges Congress to protect ClinicalTrials.gov as essential infrastructure after its shutdown, ensuring patients can access clinical trial options. BOCA RATON, FL, UNITED STATES, October 17, 2025 /⁨EINPresswire.com⁩/ -- During the ongoing …

Distribution channels: Healthcare & Pharmaceuticals Industry, Human Rights ...

Published on August 28, 2025 - 13:00 GMT

Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching

Massive Bio Launches Oracle Cerner App to Simplify Patient Records and Speed Up Clinical Trial Matching BOCA RATON, FL, UNITED STATES, August 28, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio, a leader in AI-powered oncology clinical trial matching, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 12, 2025 - 13:00 GMT

Massive Bio and Prognos Health Announce Strategic Partnership to Expand Oncology Access

Collaboration leverages Massive Bio's clinical expertise with Prognos Health's real-world data to deliver actionable intelligence for life sciences companies. BOCA RATON, FL, UNITED STATES, August 12, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio, a …

Distribution channels: Business & Economy, Companies ...

Published on July 31, 2025 - 14:07 GMT

MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant

Massive Bio launches Patient Connect & DrArturoAI, delivering on CMS’s vision with AI trial matching, secure data access & full interoperability compliance. BOCA RATON, FL, UNITED STATES, July 31, 2025 /⁨EINPresswire.com⁩/ -- In direct support of …

Distribution channels: Business & Economy, Companies ...

Published on May 30, 2025 - 13:00 GMT

Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25

Massive Bio highlights AI-driven clinical trial matching, real-world data solutions, and expert insights at the 2025 ASCO Annual Meeting. CHICAGO, IL, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Company to highlight patient-trial matching platform …

Distribution channels: Business & Economy, Companies ...

Published on April 14, 2025 - 12:00 GMT

Massive Bio Receives CNIL Certification for GDPR Compliance

Massive Bio is now authorized to process medical records in France, marking a major step in AI-driven clinical trial matching across Europe. BOCA RATON, FL, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio holds certification from the …

Distribution channels: Business & Economy, Companies ...

Published on April 14, 2025 - 12:00 GMT

Massive Bio reçoit son attestation de certification par la CNIL pour sa mise en conformité au RGPD

Massive Bio certifiée par la CNIL pour le traitement sécurisé des données de santé et l’appariement aux essais cliniques en France. BOCA RATON, FL, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio obtient son attestation de certification …

Distribution channels: Business & Economy, Companies ...

Published on February 11, 2025 - 13:18 GMT

Massive Bio Stands Committed to Accelerating Cancer Research and Clinical Trial Access Amid NIH Funding Uncertainty

A judge halted the NIH’s 15% cost rate, but research impacts remain. Massive Bio stays committed to patient access and cancer research. NEW YORK, NY, UNITED STATES, February 11, 2025 /⁨EINPresswire.com⁩/ -- A sweeping shift in federal policy—capped, at …

Distribution channels: Chemical Industry, Companies ...

Published on January 15, 2025 - 18:43 GMT

Massive Bio Recognized by White House Cancer Moonshot, Launches $15 Million Initiative at JPM 2025

Massive Bio is featured in the White House OSTP’s Cancer Moonshot Fact Sheet for advancing global cancer trial access. NEW YORK, NY, UNITED STATES, January 15, 2025 /⁨EINPresswire.com⁩/ -- Massive Bio today proudly announces its inclusion in the White …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...